Genetic uptake in BRCA-mutation families is related to emotional and behavioral communication characteristics of index patients
- PMID: 15951961
- DOI: 10.1007/s10689-004-7991-2
Genetic uptake in BRCA-mutation families is related to emotional and behavioral communication characteristics of index patients
Abstract
Introduction: Carriers of a hereditary mutation in BRCA are at high risk for breast and ovarian cancer. The first person from a family known to carry the mutation, the index person, has to share genetic information with relatives. This study is aimed at determining the number of relatives tested for a BRCA mutation, and the exploration of facilitating and debilitating factors in the transmission of genetic information from index patient to relatives.
Methods: The study includes 50 female index patients, with a germline mutation in either BRCA1 or BRCA2.
Results: The percentage of first- and second-degree relatives tested for the BRCA-mutation was 36%. Uptake levels for predictive BRCA-mutation testing could not be explained by demographic or counseling characteristics, nor by cancer-related history. In 14 families, fewer than 20% of first- and second-degree relatives were tested. These families were compared with the other families. In retrospect, the index patients of families with few BRCA-mutation tests more often asked for support in the communication with family members (62% vs. 27%). A psychosocial worker had been absent more often during counseling (39% vs. 9%). Emotional factors debilitating the information transmission were only reported by index patients from families with few BRCA-mutation tests (18% vs. 0%), who also informed their parents less often (21% vs. 67%) and did so less often personally (38% vs. 71%).
Conclusion: Uptake of predictive BRCA-mutation testing by first- and second-degree relatives is low. Emotional and behavioral factors of index patients are related to this uptake.
Similar articles
-
Uptake of predictive testing among relatives of BRCA1 and BRCA2 families: a multicenter study in northeastern Spain.Fam Cancer. 2010 Sep;9(3):297-304. doi: 10.1007/s10689-009-9313-1. Fam Cancer. 2010. PMID: 20091130
-
Childhood cancer in families with and without BRCA1 or BRCA2 mutations ascertained at a high-risk breast cancer clinic.Cancer Biol Ther. 2006 Sep;5(9):1098-102. doi: 10.4161/cbt.5.9.3167. Epub 2006 Sep 11. Cancer Biol Ther. 2006. PMID: 16931905
-
Impact of family history on choosing risk-reducing surgery among BRCA mutation carriers.Am J Obstet Gynecol. 2013 Apr;208(4):329.e1-6. doi: 10.1016/j.ajog.2013.01.026. Epub 2013 Jan 17. Am J Obstet Gynecol. 2013. PMID: 23333547
-
Decisions and ethical issues among BRCA carriers and the use of preimplantation genetic diagnosis.Minerva Med. 2009 Oct;100(5):371-83. Minerva Med. 2009. PMID: 19910890 Review.
-
Missed therapeutic and prevention opportunities in women with BRCA-mutated epithelial ovarian cancer and their families due to low referral rates for genetic counseling and BRCA testing: A review of the literature.CA Cancer J Clin. 2017 Nov;67(6):493-506. doi: 10.3322/caac.21408. Epub 2017 Sep 7. CA Cancer J Clin. 2017. PMID: 28881380 Review.
Cited by
-
Expanding the search for germline pathogenic variants for breast cancer. How far should we go and how high should we jump? The missed opportunity!Oncol Rev. 2021 Jun 24;15(1):544. doi: 10.4081/oncol.2021.544. eCollection 2021 Feb 26. Oncol Rev. 2021. PMID: 34267891 Free PMC article.
-
Implementing Systematic Genetic Counseling and Multigene Germline Testing for Individuals With Pancreatic Cancer.JCO Oncol Pract. 2021 Feb;17(2):e236-e247. doi: 10.1200/OP.20.00678. Epub 2021 Jan 13. JCO Oncol Pract. 2021. PMID: 33439686 Free PMC article.
-
Sharing genetic risk with next generation: mutation-positive parents' communication with their offspring in Lynch Syndrome.Fam Cancer. 2011 Mar;10(1):43-50. doi: 10.1007/s10689-010-9386-x. Fam Cancer. 2011. PMID: 20857224
-
The uptake of presymptomatic genetic testing in hereditary breast-ovarian cancer and Lynch syndrome: a systematic review of the literature and implications for clinical practice.Fam Cancer. 2019 Jan;18(1):127-135. doi: 10.1007/s10689-018-0089-z. Fam Cancer. 2019. PMID: 29846880
-
Cascade Testing for Hereditary Cancer Syndromes: Should We Move Toward Direct Relative Contact? A Systematic Review and Meta-Analysis.J Clin Oncol. 2022 Dec 10;40(35):4129-4143. doi: 10.1200/JCO.22.00303. Epub 2022 Aug 12. J Clin Oncol. 2022. PMID: 35960887 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous